• Publications
  • Influence
Nuclear Epidermal Growth Factor Receptor Is a Functional Molecular Target in Triple-Negative Breast Cancer
Triple-negative breast cancer (TNBC) is a subclass of breast cancers (i.e., estrogen receptor–negative, progesterone receptor–negative, and HER2-negative) that have poor prognosis and very fewExpand
  • 39
  • 5
Erlotinib is a viable treatment for tumors with acquired resistance to cetuximab
The epidermal growth factor receptor (EGFR) is a ubiquitously expressed receptor tyrosine kinase (RTK) and is recognized as a key mediator of tumorigenesis in many human tumors. Currently there areExpand
  • 15
Cancer Biology and Signal Transduction Nuclear Epidermal Growth Factor Receptor Is a Functional Molecular Target in Triple-Negative Breast Cancer
Triple-negative breast cancer (TNBC) is a subclass of breast cancers (i.e., estrogen receptor–negative, progesterone receptor–negative, and HER2-negative) that have poor prognosis and very fewExpand
Abstract LB-219: Nuclear EGFR serves as a functional molecular target in triple-negative breast cancer.
Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC Triple negative breast cancer (TNBC) is a subclass of breast cancer (i.e. estrogen receptor negative, progesteroneExpand
Partial Protection of Influenza Vaccine in a Primary Care Population—Wisconsin: 2012–2015
1Department of Family Medicine, University of Wisconsin-Madison, 2Wisconsin Division of Public Health, 3Wisconsin State Laboratory of Hygiene 4U.S. Centers for Disease Control and Prevention. TheExpand